A Draft Recommendation on Anti–Vascular Endothelial Growth Factor Drugs for Retinal Conditions is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Anti–Vascular Endothelial Growth Factor Drugs for Retinal Conditions
2015-12-16
2016-01-14…
See our latest Update for Patient Groups to learn how the thank-you letters to patient groups are prepared, how other groups complete their patient input templates, and more.
A List of Included Studies on Mismatch Repair Deficiency Testing for Patients with Colorectal Cancer: A Clinical and Cost-Effectiveness Evaluation is now available for feedback from all interested stakeholders
Project
Call for Feedback
Feedback Due By
Mismatch Repair Deficiency Testing for Patients…
Final Environmental Scan report is now available for the CADTH project on Cancer Biomarker Testing.
CADTH is updating the third edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada. To help with this initiative, we’re inviting interested stakeholders to provide input.
The guidelines detail best practices for conducting economic evaluations. The guidelines are used…
The CADTH Lecture Series provides prominent scholars and opinion leaders with a forum to discuss pressing issues facing health technology assessment (HTA) and health care today.
Join the CADTH Lecture Series for the first session of 2016. The lecture, A “Revolution”? — The Limits of Personalized…
A draft Environmental Scan on Tamper-Resistant Formulations of Opioids is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Tamper-resistant Formulations of Opioids
2015-11-30
2015-12-11
Consultation Document
Product Type
Submit Stakeholder…
The final report is now available for the CADTH project on Publicly Funded Uses of PET Scans in Canada.
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
The CADTH Lecture Series provides prominent scholars and opinion leaders with a forum to discuss pressing issues facing health technology assessment (HTA) and health care today.
Join the CADTH Lecture Series for the last session before the holidays. The lecture, Is Deliberative Public Engagement…
The final science report is now available for the CADTH project on Antihemophilic Factor (Recombinant BDD) Fc Fusion Protein (Eloctate): Treatment Cost Comparison and Budget Impact Analysis.
The final science report is now available for the CADTH project on Coagulation Factor IX FC Fusion Protein (Alprolix): Treatment Cost Comparison and Budget Impact Analysis.